Reactivation of adult-onset Still’s disease after use of the COVID-19 ChAdOx1-S vaccine
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-249290
Abstract: A woman in her 60s with a history of adult-onset Still’s disease (AOSD) in remission for 14 years received the ChAdOx1-S vaccine as a booster to her initial vaccination schedule (two doses of CoronaVac vaccine… read more here.
Keywords: adult onset; still disease; chadox1 vaccine; onset still ... See more keywords
Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.782335
Abstract: Recent reports of rare ChAdOx1-S vaccine-related venous thrombosis led to the suspension of its usage in several countries. Vaccine-induced thrombotic thrombocytopenia (VITT) is characterized by thrombocytopenia and thrombosis in association with anti-platelet factor 4 (PF4)… read more here.
Keywords: thrombotic thrombocytopenia; platelet factor; induced thrombotic; chadox1 vaccine ... See more keywords
Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Saudi Medicine"
DOI: 10.5144/0256-4947.2022.223
Abstract: BACKGROUND: The rate of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination among young and healthy participants remains unclear in Saudi… read more here.
Keywords: vaccination; infection; dose chadox1; post vaccination ... See more keywords